XML 79 R66.htm IDEA: XBRL DOCUMENT v3.22.4
FAIR VALUE MEASUREMENTS AND FINANCIAL INSTRUMENTS - Assets and Liabilities Measured at Fair Value on a Recurring Basis, Narrative (Details)
$ in Millions
 3 Months Ended 12 Months Ended
Dec. 16, 2019
USD ($)
Sep. 30, 2022
USD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
appeal
Dec. 31, 2020
USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]          
Highly liquid investments, maturity period (or less)     3 months    
Cash and cash equivalents     $ 564 $ 582 $ 605
Valeant US Securities Litigation | Settled Litigation | New Jersey          
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]          
Litigation, amount paid $ 1,210     $ 1,510  
Settlement, escrow fund included in restricted cash, number of objectors' appeals | appeal       1  
Decrease in restricted cash and other settlement deposits   $ 1,210      
Decrease in accrued and other current liabilities   $ 1,210      
Bausch + Lomb          
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]          
Cash and cash equivalents     $ 380